Medpace Holdings (MEDP) Income from Continuing Operations (2015 - 2026)
Medpace Holdings (MEDP) posted Income from Continuing Operations of 123870000.0 for Q1 2026, down 8.33% quarter-over-quarter from 135133000.0 in Q4 2025, and up 8.09% year-on-year from 114595000.0 in Q1 2025.
Medpace Holdings (MEDP) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Income from Continuing Operations for 12 consecutive years, with 123870000.0 the latest figure, recorded in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 123870000.0, up 8.09% year-over-year; the trailing twelve-month figure through Mar 2026 was 460398000.0 (up 10.57% YoY), and the FY2025 annual result was 451123000.0, up 11.56% from the prior year.
- Income from Continuing Operations was 123870000.0 for Q1 2026 at Medpace Holdings, down from 135133000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 135133000.0 in Q4 2025 and troughed at 49360000.0 in Q2 2022.
- Average Income from Continuing Operations over 5 years is 88679823.53, with a median of 88351000.0 recorded in 2024.
- Year-over-year, Income from Continuing Operations jumped 49.45% in 2024 and advanced 2.16% in 2025.
- Over 5 years, Income from Continuing Operations stood at 68670000.0 in 2022, then rose by 14.02% to 78298000.0 in 2023, then surged by 49.45% to 117018000.0 in 2024, then advanced by 15.48% to 135133000.0 in 2025, then retreated by 8.33% to 123870000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 123870000.0 in Q1 2026, 135133000.0 in Q4 2025, and 111135000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Medpace Holdings | 15.46 Bn | 14.81 Bn | 196.33 Mn | 123.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.87 Mn |
| Dec 31, 2025 | 135.13 Mn |
| Sep 30, 2025 | 111.14 Mn |
| Jun 30, 2025 | 90.26 Mn |
| Mar 31, 2025 | 114.60 Mn |
| Dec 31, 2024 | 117.02 Mn |
| Sep 30, 2024 | 96.43 Mn |
| Jun 30, 2024 | 88.35 Mn |
| Mar 31, 2024 | 102.59 Mn |
| Dec 31, 2023 | 78.30 Mn |
| Sep 30, 2023 | 70.55 Mn |
| Jun 30, 2023 | 61.07 Mn |
| Mar 31, 2023 | 72.89 Mn |
| Dec 31, 2022 | 68.67 Mn |
| Sep 30, 2022 | 66.03 Mn |
| Jun 30, 2022 | 49.36 Mn |
| Mar 31, 2022 | 61.31 Mn |
| Dec 31, 2021 | 50.03 Mn |
| Sep 30, 2021 | 48.57 Mn |
| Jun 30, 2021 | 39.93 Mn |